RAHWAY, N.J., June 28, 2024--CDC’S ACIP Unanimously Recommends Merck’s CAPVAXIVE (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults
Merck stock tumbled under its 50-day moving average Thursday after the FDA rejected its Daiichi Sankyo-partnered cancer drug.
Merck's (NYSE:MRK) stock is up by 2.7% over the past week. Given that the markets usually pay for the long-term...